Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Oct 14, 2009; 15(38): 4794-4798
Published online Oct 14, 2009. doi: 10.3748/wjg.15.4794
Published online Oct 14, 2009. doi: 10.3748/wjg.15.4794
Figure 1 Categorical change in body weight at the last visit compared to the baseline reading.
Most of the control group (91%) remained stable, within a 5% change, compared to weight at the baseline. However, only 60% of the PPI group remained stable. In addition, compared with 4% of the control group, 36% of patients had a more than 5% increase above the baseline in body weight (P < 0.0001). n: Number of patients or control subjects.
- Citation: Yoshikawa I, Nagato M, Yamasaki M, Kume K, Otsuki M. Long-term treatment with proton pump inhibitor is associated with undesired weight gain. World J Gastroenterol 2009; 15(38): 4794-4798
- URL: https://www.wjgnet.com/1007-9327/full/v15/i38/4794.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.4794